Read The Latest Article, Engaging With Patients And Experts To Develop New Drugs

How we help
- How we help ›
- Clinical pharmacologyWe have over 40 years of experience in First-in-Human studies, Phases I-IIa studies.
- Clinical developmentAs a new breed of CRO, we offer full service solutions with international reach.
- Full service solutionsOur fully integrated service solutions
- Therapeutic expertise
Resources
- Resources ›
- WebinarsThe latest in clinical development, available on demand.
- BrochuresSpecialist brochures designed to inform and inspire.
- White papersExpand your knowledge with our research papers.
- VideosInterviews with our experts about their work.
- Case StudiesOur case studies can support your professional practise and enhance your knowledge.
About us
- Who we areDiscover more about the people behind the full service agile CRO.
- Join our teamInspiring reasons to start a career at Simbec-Orion.
- NewsPast and present press coverage. Read all about us.
- EventsSee which conferences we’ll be attending, and where.
Contact us

Dr Fabrice Chartier explains the complex nature of developing treatments for rare diseases. Read the article on page 17.

≪ Back to News